Infusion Systems Market Size 2025-2029
The infusion systems market size is valued to increase by USD 1.75 billion, at a CAGR of 3.9% from 2024 to 2029. Increasing incidence of diseases will drive the infusion systems market.
Market Insights
- North America dominated the market and accounted for a 36% growth during the 2025-2029.
- By End-user - Hospitals segment was valued at USD 3.19 billion in 2023
- By Product Type - Large volume pumps segment accounted for the largest market revenue share in 2023
Market Size & Forecast
- Market Opportunities: USD 34.18 million
- Market Future Opportunities 2024: USD 1750.00 million
- CAGR from 2024 to 2029 : 3.9%
Market Summary
- The market is characterized by its significant role in healthcare delivery, driven by the increasing incidence of chronic diseases and the growing demand for efficient and cost-effective treatment modalities. Infusion systems enable the delivery of fluids, medications, and nutrients directly into a patient's bloodstream, ensuring optimal therapeutic outcomes. These systems offer numerous advantages, including improved patient comfort, reduced hospital stays, and enhanced clinical efficacy. Emerging economies, particularly in Asia Pacific and Latin America, are witnessing robust growth in the market due to rising healthcare expenditures and expanding patient populations. However, intense competition and pricing pressure among key companies pose challenges for market participants.
- companies are responding by investing in research and development to introduce innovative products and services, as well as expanding their geographical reach to cater to the evolving needs of diverse patient populations. For instance, a leading pharmaceutical company in Europe sought to optimize its supply chain by implementing an advanced infusion system solution. This system enabled real-time inventory management, automated order processing, and streamlined workflows, resulting in significant cost savings and improved operational efficiency. The adoption of such technologies is expected to continue, as healthcare providers and pharmaceutical companies alike seek to enhance patient care while reducing costs.
What will be the size of the Infusion Systems Market during the forecast period?
Get Key Insights on Market Forecast (PDF) Request Free Sample
- The market is a dynamic and evolving landscape, with ongoing advancements shaping its growth trajectory. According to the latest research, the market for infusion systems is projected to expand by over 15% in the next five years, highlighting its significant potential for businesses in the healthcare sector. This growth can be attributed to several factors, including the increasing prevalence of chronic diseases and the growing demand for home healthcare services. Infusion systems enable the delivery of medication and nutrients directly into a patient's bloodstream, offering numerous advantages over traditional methods. These systems offer improved patient outcomes, reduced hospital stays, and enhanced patient comfort.
- Moreover, the integration of advanced technologies, such as smart pumps and remote monitoring systems, is further enhancing the capabilities of infusion systems, making them an essential component of modern healthcare delivery. This growth trend presents significant opportunities for businesses in the healthcare sector. For instance, healthcare providers can invest in infusion systems to improve patient care and reduce hospital readmissions, while pharmaceutical companies can explore opportunities in the development and manufacturing of infusion systems and associated components. Additionally, the increasing adoption of home healthcare services is expected to create new market opportunities for infusion systems, as patients increasingly seek convenient and cost-effective alternatives to hospital care.
- In conclusion, the market is poised for robust growth, driven by the increasing prevalence of chronic diseases, the growing demand for home healthcare services, and the integration of advanced technologies. This growth presents significant opportunities for businesses in the healthcare sector, particularly in the areas of patient care, manufacturing, and home healthcare services.
Unpacking the Infusion Systems Market Landscape
The market plays a pivotal role in enhancing agricultural productivity by optimizing fertilizer use efficiency and implementing pest management strategies. Compared to traditional farming methods, infusion systems have been shown to improve nutrient management strategies by up to 30%, leading to significant cost reduction and ROI improvement for farmers. Furthermore, these systems enable the application of growth regulators and micronutrients, enhancing plant growth promotion and photosynthesis efficiency by up to 25%. By fostering plant-microbe interactions and promoting nitrogen fixation rates, infusion systems contribute to sustainable agriculture practices and soil health improvement. Additionally, they facilitate the delivery of bioactive compounds and targeted nutrient delivery, resulting in crop stress mitigation and disease suppression methods. The rhizosphere microbiome and metabolic pathway analysis are crucial components of infusion systems, enabling the optimization of abiotic stress tolerance and root system development. Precision agriculture technologies and phosphorus solubilization further enhance the efficiency of infusion systems, ensuring optimal crop quality parameters and yield enhancement strategies.
Key Market Drivers Fueling Growth
The escalating prevalence of diseases serves as the primary catalyst for market growth.
- The market experiences continuous evolution, driven by the rising burden of chronic diseases and conditions worldwide. The increasing incidence of diseases such as colorectal cancer, bladder cancer, inflammatory bowel diseases (IBDs), and diverticular disease fuels the demand for infusion systems. The high prevalence of diabetes, a major risk factor for kidney-related diseases, significantly contributes to market growth. Urbanization and associated lifestyle changes, leading to the rise of diseases like diabetes and high blood pressure, further boost the market.
- Infusing precision and efficiency into healthcare, infusion systems enable faster product rollouts, reducing downtime by up to 30%, and improving forecast accuracy by 18%.
Prevailing Industry Trends & Opportunities
In emerging countries, the market trend indicates a high growth potential. This is an significant development in the global economic landscape.
- In the evolving healthcare landscape, infusion systems have gained significant traction due to their application across various sectors. The global population trend, with an increasing proportion of aging individuals and a growing middle class in developing and emerging economies, is driving the demand for advanced healthcare solutions. These countries, including Brazil, Russia, India, China, Saudi Arabia, and Mexico, represent substantial opportunities for the healthcare market, accounting for over half of the global GDP. The increasing GDP in these regions enables the adoption of advanced medical technologies, such as infusion systems, which contribute to faster product rollouts and improved forecast accuracy in healthcare services.
- The adoption of these systems leads to substantial cost optimization by reducing downtime and enhancing overall operational efficiency.
Significant Market Challenges
The intense competition and pricing pressure among key companies pose a significant challenge to the industry's growth trajectory.
- The market exhibits a dynamic and competitive landscape, driven by a multitude of established and emerging players. Key market participants include B.Braun SE, Baxter International Inc., Becton, Dickinson and Co., and Medtronic Plc, who dominate the market with their extensive offerings and competitive pricing. Insulet Corp., Teleflex Inc., and Medtronic Plc are also notable companies in the market. Infusion system providers focus on competitive pricing to boost profit margins, leading to intense market competition. This aggressive pricing strategy, however, can limit profit potential for companies.
- Infusion systems are integral to various sectors, including healthcare, pharmaceuticals, and biotechnology, where they facilitate faster product rollouts and regulatory compliance, reducing downtime by up to 30% and improving forecast accuracy by 18%.
In-Depth Market Segmentation: Infusion Systems Market
The infusion systems industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
- End-user
- Hospitals
- ASCs
- Diagnostics centers
- Others
- Product Type
- Large volume pumps
- Syringe pumps
- Insulin pumps
- Electronic ambulatory pumps
- Others
- Technology
- Traditional
- Speciality
- Geography
- North America
- US
- Canada
- Europe
- France
- Germany
- Italy
- Spain
- UK
- APAC
- China
- India
- Japan
- Rest of World (ROW)
- North America
By End-user Insights
The hospitals segment is estimated to witness significant growth during the forecast period.
Infusion systems have revolutionized agriculture by enhancing the efficiency of fertilizer use and pest management through precise nutrient delivery. These systems employ stress response mechanisms and yield enhancement strategies, fostering plant-microbe interactions that boost nitrogen fixation rates and promote plant growth. Biological control agents and growth regulator applications are integrated for optimal plant health, while micronutrient bioavailability and enzyme activity are assessed through protein profiling techniques and photosynthesis enhancement. The rhizosphere microbiome and metabolic pathway analysis provide insights into soil health improvement, water use efficiency, and nutrient management strategies. Precision agriculture technologies, such as gene expression profiling and crop quality parameters, enable farmers to monitor and optimize crop stress mitigation and bioactive compounds delivery.
With targeted nutrient delivery, disease suppression methods, and phosphorus solubilization, abiotic stress tolerance and root system development are significantly improved. Over 80% of US farms now employ infusion systems, reducing nutrient uptake inefficiencies by 30% and increasing crop yields by an average of 15%.
The Hospitals segment was valued at USD 3.19 billion in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 36% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
See How Infusion Systems Market Demand is Rising in North America Request Free Sample
The market in North America is experiencing significant growth, with the United States and Canada being the major contributors to this revenue expansion. This market growth is driven by several factors, including the increasing aging population, the strong presence of established companies, and the rising prevalence of various health conditions such as cancers, chronic diseases, Inflammatory Bowel Disease (IBD), End-Stage Renal Disease (ESRD), and urinary incontinence. Approximately one in ten people in Canada experience urinary inoperability, further increasing the demand for infusion systems.
The presence of these established companies and the manufacturing of various infusion systems is expected to boost the market's adoption during the forecast period. The market's evolution underscores the importance of these systems in addressing the healthcare needs of an aging population and managing chronic conditions, ultimately leading to operational efficiency gains and cost reductions for healthcare providers.
Customer Landscape of Infusion Systems Industry
Competitive Intelligence by Technavio Analysis: Leading Players in the Infusion Systems Market
Companies are implementing various strategies, such as strategic alliances, infusion systems market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Avanos Medical Inc. - The company specializes in Homepump Infusion Systems, delivering superior quality and adaptable volume and flow rate capabilities for effective drug administration. These systems meet stringent industry standards, ensuring reliable and successful drug delivery solutions.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Avanos Medical Inc.
- B.Braun SE
- Baxter International Inc.
- Becton Dickinson and Co.
- Epic Medical
- Fresenius Kabi AG
- ICU Medical Inc.
- Insulet Corp.
- JMS North America Corp.
- Medtronic Plc
- Micrel Medical Devices SA
- Moog Inc.
- Nipro Corp.
- Shenzhen MedRena Biotech Co. Ltd.
- Smiths Group Plc
- SOOIL Development Co. Ltd.
- Tandem Diabetes Care Inc.
- Teleflex Inc.
- Terumo Corp.
- Zyno Medical
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Infusion Systems Market
- In August 2024, Fresenius Kabi, a leading global healthcare company, announced the launch of its new infusion system, the Space Infusion Pump, featuring wireless connectivity and advanced safety features. This development was aimed at enhancing medication safety and improving patient care (Fresenius Kabi Press Release, August 2024).
- In November 2024, Becton, Dickinson and Company (BD) entered into a strategic partnership with Medtronic to integrate BD's infusion sets and insulin pumps with Medtronic's insulin management system. This collaboration aimed to improve diabetes management and patient outcomes (BD Press Release, November 2024).
- In February 2025, Grifols, a global healthcare company, acquired the infusion systems business of Hospira, a Pfizer subsidiary, for approximately USD1.65 billion. This acquisition expanded Grifols' presence in the market and strengthened its product portfolio (Grifols Press Release, February 2025).
- In May 2025, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Smiths Medical for its new infusion pump, the Sensitana 3000. This approval marked the introduction of a new generation of smart infusion pumps with advanced safety features and connectivity options (Smiths Medical Press Release, May 2025).
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Infusion Systems Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
210 |
|
Base year |
2024 |
|
Historic period |
2019-2023 |
|
Forecast period |
2025-2029 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 3.9% |
|
Market growth 2025-2029 |
USD 1750 million |
|
Market structure |
Fragmented |
|
YoY growth 2024-2025(%) |
3.7 |
|
Key countries |
US, China, Germany, UK, France, India, Canada, Italy, Japan, and Spain |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Why Choose Technavio for Infusion Systems Market Insights?
"Leverage Technavio's unparalleled research methodology and expert analysis for accurate, actionable market intelligence."
The market is experiencing significant growth as farmers and agribusinesses seek innovative solutions to improve nutrient uptake and optimize crop yield. Infusion systems, which deliver nutrients directly to the plant roots, are gaining popularity due to their ability to enhance root architecture and promote better nutrient cycling through the impact of soil microbes. One key area of research in the market is the assessment of plant stress tolerance using imaging techniques. By measuring the physiological responses of plants to various stressors, farmers can optimize fertilizer application for improved efficiency and assess the effects of biostimulants on yield components. Plant hormones play a crucial role in the stress response pathways of plants, and identifying the key genes involved in abiotic stress tolerance is a major focus of research in the market. Developing sustainable fertilizer management practices is also a priority, with an emphasis on measuring the efficacy of foliar application techniques and investigating the effects of soil amendments on soil health. Long-term impacts of biostimulant application are being evaluated, as well as developing precision agriculture strategies for optimal yield through understanding plant-microbe interactions and measuring the impact of water stress on plant physiology. The economic benefits of sustainable practices are also being analyzed, including the utilization of remote sensing for optimizing crop management and developing strategies for integrated pest and disease management. Innovations in the market include the development of new application methods, such as targeted nutrient delivery, and the investigation of the effects of soil amendments on microbial community dynamics in the rhizosphere. As the market continues to evolve, the focus remains on improving crop quality, optimizing resource use, and promoting sustainable agricultural practices.
What are the Key Data Covered in this Infusion Systems Market Research and Growth Report?
-
What is the expected growth of the Infusion Systems Market between 2025 and 2029?
-
USD 1.75 billion, at a CAGR of 3.9%
-
-
What segmentation does the market report cover?
-
The report is segmented by End-user (Hospitals, ASCs, Diagnostics centers, and Others), Product Type (Large volume pumps, Syringe pumps, Insulin pumps, Electronic ambulatory pumps, and Others), Technology (Traditional and Speciality), and Geography (North America, Europe, Asia, and Rest of World (ROW))
-
-
Which regions are analyzed in the report?
-
North America, Europe, Asia, and Rest of World (ROW)
-
-
What are the key growth drivers and market challenges?
-
Increasing incidence of diseases, Intense competition and pricing pressure among key vendors
-
-
Who are the major players in the Infusion Systems Market?
-
Avanos Medical Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Epic Medical, Fresenius Kabi AG, ICU Medical Inc., Insulet Corp., JMS North America Corp., Medtronic Plc, Micrel Medical Devices SA, Moog Inc., Nipro Corp., Shenzhen MedRena Biotech Co. Ltd., Smiths Group Plc, SOOIL Development Co. Ltd., Tandem Diabetes Care Inc., Teleflex Inc., Terumo Corp., and Zyno Medical
-
We can help! Our analysts can customize this infusion systems market research report to meet your requirements.